2022

DIMER DIABETES
November 17-20, 2022

Day 1, November 17 th 2022, Thursday

13:45-14:00 OPENING CEREMONY

Speaker: Prof. Dr. Mustafa KANAT

14:00-15:30 SESSION I - PREDIABETES

Chair: Prof. Dr. Aytekin OĞUZ
14:00-14:30 Prevalence, Pathophysiology and Significance of Prediabetes
Speaker: Prof. Dr. İlhan SATMAN
14:30-15:15 Prevention of T2DM: Can it Be Achieved?
Speaker: Prof. Dr. Ralph DEFRONZO
15:15-15:30 Discussion

15:30-15:45 COFFEE BREAK

15:45-16:45 SESSION II - A CLINICAL UPDATE ON GESTATIONAL DIABETES

Chair: Prof. Dr. İlhan SATMAN
15:45-16:35 Gestational Diabetes: Mechanisms and Treatment
Speaker: Prof. Dr. Mustafa KANAT
16:35-16:45 Discussion

16:45-17:50 SESSION III - OBESITY

Chair: Prof. Dr. Ofri MOSENZON
16:45-17:35 Is it a Disease or Just a Lifestyle Choice?
Speaker: Prof. Dr. Mehmet SARGIN
17:35-17:50 Discussion
 Day 2, November 18th 2022, Friday

SESSION IV - PLENARY LECTURE:

09:00-10:00
PATHOPHYSIOLOGIC APPROACH TO THERAPY in T2DM
Chair: Prof. Dr. Hasan İLKOVA
09:00-09:45 Plenary Lecture: Pathophysiologic Approach to Therapy in T2DM
Speaker: Prof. Dr. Ralph DEFRONZO
09:45-10:00 Discussion

10:00-10:15 COFFEE BREAK

10:15-12:00 SESSION V - GLP-1 RA & T2DM

Chair: Prof. Dr. Dilek GOGAS YAVUZ
10:15-11:00 The Place of GLP-1 RA in T2DM: Glucose Control and Beyond
Speaker: Prof. Dr. Michael NAUCK
11:00-11:45 Hybrid Peptides
Speaker: Prof. Dr. Michael NAUCK
11:45-12:00 Discussion

12:00-12:50 SATELLITE SYMPOSIUM 1

12:00-12:50 Dapagliflozin, Type 2 Diabetes and Beyond Q&A with DeFronzo
Speaker: Prof. Dr. Ralph DEFRONZO

12:50-13:50 LUNCH BREAK

13:50-16:20 SESSION VI - SGLT2i & T2DM

Chairs: Prof. Dr. Tevfik ECDER, Prof. Dr. Mustafa ARICI
13:50-14:35 SGLT2i: Glucose Homeostasis and Kidney
Speaker: Prof. Dr. Mustafa KANAT
14:35-15:20 SGLT2i is a Cardioprotective Drug
Speaker: Prof. Dr. Muhammad ABDUL-GHANI
15:20-16:05 Treatment of Diabetic Nephropathy: A Mechanistic Approach
Speaker: Prof. Dr. Ralph DEFRONZO
16:05-16:20 Discussion

16:20-16:35 COFFEE BREAK

16:35-17:50 SESSION VII -INSULIN THERAPY IN T2DM
Chair: Prof. Dr. Paolo POZZILI
16:35-17:05 When to Use Insulin Therapy?
Speaker: Prof. Dr. Muhammad ABDUL-GHANI
17:05-17:35 Combination of Insulin Plus Other Agents
Speaker: Prof. Dr. Mustafa ARAZ
17:35-17:50 Discussion

17:50-18:35 SESSION VIII - DIABETES COMPLICATIONS

Chair: Prof. Dr. Mustafa KANAT
17:50-18:20 Diabetic Neuropathy
Speaker: Prof. Dr. Rayaz MALIK
18:20-18:35 Discussion

Day 3, November 19 th 2022, Saturday

09:00-10:15 SESSION IX - MANAGEMENT OF T2DM

Chair: Prof. Dr. Muhammad ABDUL-GHANI
09:00-09:30 The Current Guidelines are Suitable
Speaker: Prof. Dr. Mustafa Kemal BALCI
09:30-10:00 Initial Combination Therapy is the Way to Go?
Speaker: Prof. Dr. Ofri MOSENZON
10:00-10:15 Discussion

10:15-10:30 COFFEE BREAK

10:30-11:30 SESSION X - THIAZOLIDINEDIONES & T2DM

Chair: Prof. Dr. Mustafa ARAZ
10:30-11:15 Thiazolidinediones & T2DM
Speaker: Prof. Dr. Ralph DEFRONZO
11:15-11:30 Discussion
11:30-12:20 SATELLITE SYMPOSIUM 2
11:30-12:20 From Past to Present in T2DM Treatment:
Cardio-Renal-Metabolic Benefits with Empagliflozin
Speaker: Prof. Dr. Dilek GOGAS YAVUZ, Prof. Dr. M. Birhan YILMAZ
Prof. Dr. Mustafa ARICI

12:20-13:20 LUNCH BREAK

13:20-14:05 SESSION XI - T2DM & SUBCLASSIFICATION

Chair: Prof. Dr. Ralph DEFRONZO
13:20-13:50 Is T2DM a Wrong Diagnosis?
Speaker: Prof. Dr. Dilek GOGAS YAVUZ
13:50-14:05 Discussion

14:05-15:20 SESSION XII - DIABETES COMPLICATIONS

Chairs: Prof. Dr. Zobair M. YOUNASSI, Prof. Dr. Muhammad ABDUL-GHANI
14:05-14:35 Management of CKD in T2DM
Speaker: Prof. Dr. Ofri MOSENZON
14:35-15:05 How to Prevent CV Events
Speaker: Prof. Dr. Vivian FONSECA
15:05-15:20 Discussion

15:20-15:40 COFFEE BREAK

15:40-16:40 SESSION XIII - LIVER IN DIABETES

Chair: Prof. Dr. Ofri MOSENZON
15:40-16:25 Liver in Diabetes
Speaker: Prof. Dr. Zobair M. YOUNOSSI
16:25-16:40 Discussion

16:40-17:30 SESSION XIV - TRIPLE THERAPY: THE EDICT STUDY

Chair: Prof. Dr. Muhammad ABDUL-GHANI
Speaker: Prof. Dr. Ralph DEFRONZO
 Day 4, November 20 th 2022, Sunday

09:00-10:30 SESSION XV - T1DM

Chairs: Prof. Dr. Rayaz MALIK, Prof. Dr. Hasan İLKOVA
09:00-09:45 Adjuvant Therapies to Insulin in T1DM
Speaker: Prof. Dr. Paolo POZZILI
09:45-10:15 How Technology Can Advance T1DM Management
Speaker: Prof. Dr. Oğuzhan DEYNELİ
10:15-10:30 Discussion

10:30-11:20 SESSION XVI - CASE STUDY

10:30-11:20 Moderator: Prof. Dr. Muhammad ABDUL-GHANI

11:20-11:35 COFFEE BREAK

11:35-13:05 ORAL ABSTRACT PRESENTATIONS

Chairs: Ass. Prof. Dr. Bülent CAN, Ass. Prof. Dr. İrfan NUHOĞLU
11:35-11:45 Dr. Arzu GÜNTÜRK
11:45-11:55 Dr. Gökhan UYGUN
11:55-12:05 Dr. Serpil ÇİFTEL
12:05-12:15 Dr. Mustafa GÜMÜŞ
12:15-12:25 Dr. Yusuf ÖZTÜRK
12:25-12:35 Dr. Hacer Hicran MUTLU
12:35-12:45 Dr. Hacer Hicran MUTLU
12:45-12:55 Dr. Hilmi Erdem SÜMBÜL
12:55-13:05 Dr. Abdüsselam ŞEKERCİ

13:05-13:35 SUMMARY AND CLOSING REMARKS

Speaker: Prof. Dr. Mustafa KANAT
Postgraduate Course Faculty
Prof. Dr. Ralph DEFRONZO, USA
Prof. Dr. Mustafa KANAT, Turkey
Prof. Dr. Vivian FONSECA , USA
Prof. Dr. Michael NAUCK, Germany
Prof. Dr. İlhan SATMAN, Turkey
Prof. Dr. Hasan İLKOVA, Turkey
Prof. Dr. Muhammad ABDUL-GHANI, USA
Prof. Dr. Mustafa Kemal BALCI, Turkey
Prof. Dr. Tevfik ECDER, Turkey
Prof. Dr. Mustafa ARICI, Turkey
Prof. Dr. Paolo POZZILI, İtaly
Prof. Dr. Dilek GOGAS YAVUZ, Turkey
Prof. Dr. Devjit TRIPATHY, USA
Prof. Dr. Zobair M. YOUNOSSI, USA
Prof. Dr. Mustafa ARAZ, Turkey
Prof. Dr. Rayaz MALIK, Qatar
Prof. Dr. Oğuzhan DEYNELİ, Turkey
Prof. Dr. Ofri MOSENZON, Israel
Prof. Dr. Aytekin OĞUZ, Turkey
Prof. Dr. Mehmet SARGIN, Turkey
Prof. Dr. Kubilay KARŞIDAĞ, Turkey
Prof. Dr. Carolina SOLIS-HERRERA, USA
Ass. Prof. Dr. Seyit UYAR, Turkey
Ass. Prof. Dr. Nizameddin KOCA, Turkey
Ass. Prof. Dr. Yasin ŞAHİNTÜRK, Turkey
Ass. Prof. Dr. Gülşah Y. YALIN, Turkey
Ass. Prof. Dr. Bülent CAN, Turkey
Ass. Prof. Dr. İrfan NUHOĞLU, Turkey